Announce Date | 08/08/2024 |
EPS Normalized Actual | $0.21 In Line |
EPS GAAP Actual | $0.21 In Line |
Revenue Actual | $0.189881B |
Revenue Surprise | Beat by $189.881M |
Announce Date | 07/01/2024 (Pre-Market) |
EPS Normalized Estimate | $0.21347 |
EPS GAAP Estimate | $0.21347 |
Revenue Estimate | $0.184866724B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 1.3 | 14.73 | 1.25072 | 1.39115 | 1 |
Dec 2025 | 0.47054 | 40.7 | 0.3727 | 0.69 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.09 | 0.09 | 0.189881B | 30.45% | 189.88M |
FQ4 2021 (Dec 2021) | 0.1 | 0.1 | 0.212532B | 100% | 212.53M |
FQ3 2021 (Sep 2021) | 0.11 | 0.11 | 0.192867B | 100% | 192.87M |
FQ2 2021 (Jun 2021) | 0.03 | 0.03 | 0.174826B | 100% | 174.83M |
FQ1 2021 (Mar 2021) | -0.129 | -0.129 | 0.13207B | 100% | 132.07M |
FQ3 2009 (Sep 2009) | 0.19 | 0.19 | 0.169566B | -11.05% | 169.57M |
FQ2 2009 (Jun 2009) | 0.22 | 0.22 | 0.178009B | -9.85% | 178.01M |
FQ1 2009 (Mar 2009) | 0.18 | 0.18 | 0.203018B | 0.36% | 203.02M |
FQ4 Announce Date
07/01/2024 (Pre-Market)
Consensus EPS Estimates
0.21347
Consensus Revenue Estimates
0.184866724B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.34 | -- | 0.33642 | 0.3443 | 3 |
FQ3 2026 (Sep 2026) | 0.31 | -- | 0.30674 | 0.31392 | 3 |
FQ2 2026 (Jun 2026) | 0.29 | -- | 0.28695 | 0.29366 | 3 |
FQ1 2026 (Mar 2026) | 0.25 | -- | 0.24737 | 0.25316 | 3 |
FQ4 2025 (Oct 2025) | 0.29 | -- | 0.28495 | 0.30184 | 2 |
FQ3 2025 (Jul 2025) | 0.24 | -- | 0.23582 | 0.2498 | 2 |
FQ2 2025 (Jun 2025) | 0.27 | -- | 0.26268 | 0.28715 | 2 |
FQ1 2025 (Mar 2025) | 0.23333 | -- | 0.227 | 0.24815 | 2 |
FQ4 2024 (Oct 2024) | 0.25865 | -- | 0.25415 | 0.26921 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.25B | -- | 0.25B | 0.26B | 4 |
FQ3 2026 (Sep 2026) | 0.24B | -- | 0.24B | 0.24B | 4 |
FQ2 2026 (Jun 2026) | 0.21B | -- | 0.21B | 0.22B | 4 |
FQ1 2026 (Mar 2026) | 0.2B | -- | 0.2B | 0.2B | 4 |
FQ4 2025 (Oct 2025) | 0.23B | -- | 0.22B | 0.23B | 1 |
FQ3 2025 (Jul 2025) | 0.2B | -- | 0.2B | 0.21B | 1 |
FQ2 2025 (Jun 2025) | 0.21B | -- | 0.2B | 0.22B | 1 |
FQ1 2025 (Mar 2025) | 0.19B | -- | 0.19B | 0.2B | 1 |
FQ4 2024 (Oct 2024) | 0.21B | -- | 0.2B | 0.21B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.09 | 0.09 | 100% | |
FQ4 2021 (Dec 2021) | 0.1 | 0.1 | 100% | |
FQ3 2021 (Sep 2021) | 0.11 | 0.11 | 100% | |
FQ2 2021 (Jun 2021) | 0.03 | 0.03 | 100% | |
FQ1 2021 (Mar 2021) | -0.129 | -0.129 | 100% | |
FQ3 2009 (Sep 2009) | 0.19 | 0.19 | 100% | |
FQ2 2009 (Jun 2009) | 0.22 | 0.22 | 100% | |
FQ1 2009 (Mar 2009) | 0.18 | 0.18 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.19B | $189.88M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.21B | $212.53M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.19B | $192.87M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.17B | $174.83M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.13B | $132.07M | 100% |
FQ3 2009 (Sep 2009) | $0B | $0.17B | $169.57M | 100% |
FQ2 2009 (Jun 2009) | $0B | $0.18B | $178.01M | 100% |
FQ1 2009 (Mar 2009) | $0B | $0.2B | $203.02M | 100% |